Figures
Fig 4 is incorrect. The authors have provided a corrected version here.
Three clinical variables independently associated with reduced UPE in term 1 in comparison to term 0 (RAASi use at term 0, ICR at term 0, and salt reduction in term 1 vs. term 0) were further subjected to multivariable logistic analyses for the interactions. Three combinations of each variable—RAASi use vs. ICR, RAASi use vs. salt reduction, and salt reduction vs. ICR—were analyzed. Patients without either of the variables were used as reference. Log-transformed values for adjusted ORs with 95% CIs, p values, and p for interactions are presented. Ref., reference; CR, complete remission of proteinuria; ICR, incomplete remission of proteinuria; UPE, urinary protein excretion; RAASi, renin-angiotensin aldosterone system inhibitors; OR, odds ratio; CI, confidence interval.
Reference
- 1. Tsuboi N, Sasaki T, Kashihara N, Yokoo T (2021) Proteinuria changes in kidney disease patients with clinical remission during the COVID-19 pandemic. PLoS ONE 16(4): e0250581. https://doi.org/10.1371/journal.pone.0250581 pmid:33891663
Citation: Tsuboi N, Sasaki T, Kashihara N, Yokoo T (2021) Correction: Proteinuria changes in kidney disease patients with clinical remission during the COVID-19 pandemic. PLoS ONE 16(8): e0256255. https://doi.org/10.1371/journal.pone.0256255
Published: August 11, 2021
Copyright: © 2021 Tsuboi et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.